Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-046891
Filing Date
2013-08-19
Accepted
2013-08-19 17:12:35
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v353175_10q.htm 10-Q 468306
2 EXHIBIT 31.1 v353175_ex31-1.htm EX-31.1 9416
3 EXHIBIT 31.2 v353175_ex31-2.htm EX-31.2 9366
4 EXHIBIT 32.1 v353175_ex32-1.htm EX-32.1 4073
5 EXHIBIT 32.2 v353175_ex32-2.htm EX-32.2 4058
  Complete submission text file 0001144204-13-046891.txt   6259425

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT erb-20130630.xml EX-101.INS 551170
7 XBRL TAXONOMY EXTENSION SCHEMA erb-20130630.xsd EX-101.SCH 51786
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE erb-20130630_cal.xml EX-101.CAL 41172
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE erb-20130630_def.xml EX-101.DEF 278049
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE erb-20130630_lab.xml EX-101.LAB 257990
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE erb-20130630_pre.xml EX-101.PRE 311566
Mailing Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127
Business Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127 305-324-2300
ERBA Diagnostics, Inc. (Filer) CIK: 0001095858 (see all company filings)

EIN.: 113500746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14798 | Film No.: 131048942
SIC: 2834 Pharmaceutical Preparations